Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Debord

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Cellular and Molecular Life Sciences : CMLS|September 12, 2006
Bioterrorism: management of major biological agentsP Bossi, D Garin, A Guihot, et al.
Annales De Dermatologie Et De Venereologie|April 9, 2002
[Cutaneous manifestations of bioterrorism]F Carsuzaa, T Debord, T Boye, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1996
Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progressionM L Gougeon, H Lecoeur, A Dulioust, et al.
Annales De Radiologie|January 1, 1990
[Pyomyositis in AIDS. Apropos of a case]J L Vicens, D Aubspin, R Buchon, et al.
The Journal of Infectious Diseases|July 9, 1999
The ALBI trial: a randomized controlled trial comparing stavudine plus didanosine with zidovudine plus lamivudine and a regimen alternating both combinations in previously untreated patients infected with human immunodeficiency virusJ M Molina, G Chêne, F Ferchal, et al.
Antiviral Therapy|July 19, 2005
Results of the ALBI trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patientsJ M Molina, G Chêuc, F Ferchal, et al.
Vaccine|January 27, 2009
Vaccination in adults with auto-immune disease and/or drug related immune deficiency: results of the GEVACCIM Delphi surveyP Duchet-Niedziolka, O Launay, Z Coutsinos, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Cellular and Molecular Life Sciences : CMLS|September 12, 2006
Bioterrorism: management of major biological agentsP Bossi, D Garin, A Guihot, et al.
Annales De Dermatologie Et De Venereologie|April 9, 2002
[Cutaneous manifestations of bioterrorism]F Carsuzaa, T Debord, T Boye, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1996
Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progressionM L Gougeon, H Lecoeur, A Dulioust, et al.
Annales De Radiologie|January 1, 1990
[Pyomyositis in AIDS. Apropos of a case]J L Vicens, D Aubspin, R Buchon, et al.
The Journal of Infectious Diseases|July 9, 1999
The ALBI trial: a randomized controlled trial comparing stavudine plus didanosine with zidovudine plus lamivudine and a regimen alternating both combinations in previously untreated patients infected with human immunodeficiency virusJ M Molina, G Chêne, F Ferchal, et al.
Antiviral Therapy|July 19, 2005
Results of the ALBI trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patientsJ M Molina, G Chêuc, F Ferchal, et al.
Vaccine|January 27, 2009
Vaccination in adults with auto-immune disease and/or drug related immune deficiency: results of the GEVACCIM Delphi surveyP Duchet-Niedziolka, O Launay, Z Coutsinos, et al.
Pageof 5